23Andme co-founder of CEO Wojcicki after the bankruptcy registration

A look at the 23Andme headquarters in Sunnyvale, California, on March 25, 2025.

Tayfun Coskun | Anadolu Getty Images

23andme Co-founder Linda Avey went to social media on Wednesday, to have frustrated the fate of the once difficult genetic test company, which this week entered into the insolvency protection of Chapter 11 in Chapter 11.

Avey helped in 2006 with Paul Cuenza and Anne Wojcicki, who had resigned as CEO on Friday. The company became in the mainstream due to its popular DNA test kits at home, but has fought in recent years to achieve recurring income, to increase viable therapeutic agencies and research companies and to take into account data protection concerns.

“My time in the company was shortened in 2009 when my co-founder Anne convinced the board of directors that she should lead the company,” Avey wrote in a post on the social media website X. “And I have to be honest, I was frustrated with the instruction that the company took on this point.”

23Andme, which reached a main market capitalization of around 6 billion US dollars, was completed on Wednesday from the market.

“Without continued consumer -oriented product development and without governance, 23Andme has lost its way, and society missed an important opportunity to promote the idea of ​​personalized health,” wrote Avey.

Last March, the independent directors of 23Andme formed a special committee to evaluate the company's potential paths. All seven members resigned from the board in September and said they did not agree with Wojcicki about the “strategic orientation of the company”.

“After my departure, she argued a majority for herself that removed the governance of the administrative rate, even when she expanded in the following financing rounds,” said Avey. “For the good or bad, the money heard from her. It was no surprise when the board resigned last year.”

Wojcicki submitted several suggestions to take the company privately, but everyone was rejected, even after the company had appointed new board members. The special committee “decided to unanimously reject the latest proposal from Wojcicki's in the early this month.

If the 23Ande plan is approved by the court by the court, the company will “obtain actively qualified offers” using a 45-day procedure. Wojcicki is still planning to pursue the company as an independent bidder, she said in a post on X on Monday.

“There are many warning stories in 23Andme history,” said Avey. “It is important to make a balance between the desire for start -up control and the supervision of the board. Otherwise you have a board?”

23Andme did not react immediately to the request from CNBC for comment.

Do not miss these findings from CNBC Pro